<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03780985</url>
  </required_header>
  <id_info>
    <org_study_id>IUD-Zahraa</org_study_id>
    <nct_id>NCT03780985</nct_id>
  </id_info>
  <brief_title>Post-placental Intrauterine Device Insertion During Cesarean Section</brief_title>
  <official_title>Hang-up Versus Non-fixation Technique for Immediate Post-placental Intrauterine Device Insertion During Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Effective, reversible postpartum contraception decreases the chance of rapid repeat pregnancy&#xD;
      and poor perinatal outcome in a subsequent pregnancy especially in women delivered by&#xD;
      cesarean section.The traditional 6-week postpartum visits not evidenced based and may not&#xD;
      meet patient needs, particularly with respect to provision of contraception.Intrauterine&#xD;
      device placement after delivery of the placenta is an appealing strategy for increasing&#xD;
      access to postpartum Intrauterine device because it does not require a separate postpartum&#xD;
      visit.&#xD;
&#xD;
      Advantage of post-placental Intrauterine device insertion, Intrauterine devices are&#xD;
      recommended as first-line contraceptives by the American Academy of Pediatricians. The&#xD;
      Centers for Disease Control and Prevention united state . Medical Eligibility Criteria for&#xD;
      Contraceptive Use places no restrictions on use, and states advantages generally outweigh the&#xD;
      risks for immediate postpartum use of Intrauterine devices.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">April 1, 2020</completion_date>
  <primary_completion_date type="Actual">February 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of displaced intrauterine device after insertion in both groups</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">118</enrollment>
  <condition>Intrauterine Device Migration</condition>
  <arm_group>
    <arm_group_label>intrauterine device insertion with a suture fixation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intruterine device through hysterotomy incision during cesarean section with a suture fixation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intrauterine device insertion without a suture fixation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IUD through hysterotomy incision during cesarean section without a suture fixation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intrauterine device insertion</intervention_name>
    <description>Post-placental insertion of intrauterine device during Cesarean section</description>
    <arm_group_label>intrauterine device insertion with a suture fixation</arm_group_label>
    <arm_group_label>intrauterine device insertion without a suture fixation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cesarean section</intervention_name>
    <description>to delivery of the fetus</description>
    <arm_group_label>intrauterine device insertion with a suture fixation</arm_group_label>
    <arm_group_label>intrauterine device insertion without a suture fixation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Suture</intervention_name>
    <description>to fix the intrauterine device</description>
    <arm_group_label>intrauterine device insertion with a suture fixation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age group : 18-40 years&#xD;
&#xD;
          2. Women who will be willing to undergo elective cesarean section&#xD;
&#xD;
          3. women desire using Copper IUD as long acting contraceptive method.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Intrauterine infection.&#xD;
&#xD;
          2. Fundal Myoma.&#xD;
&#xD;
          3. Hemorrhagic disorder&#xD;
&#xD;
          4. Genital tract malignancy&#xD;
&#xD;
          5. Uterine atony&#xD;
&#xD;
          6. Sexually transmitted infection.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Woman's Health Hospital - Assiut university</name>
      <address>
        <city>Assiut</city>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>December 18, 2018</study_first_submitted>
  <study_first_submitted_qc>December 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2018</study_first_posted>
  <last_update_submitted>September 9, 2021</last_update_submitted>
  <last_update_submitted_qc>September 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Abdelrahman Mahmoud Mohammed</investigator_full_name>
    <investigator_title>Assistant Lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intrauterine Device Migration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

